文献速递脑血管病

急性缺血性卒中黄金小时静脉溶栓:系统评价与Meta分析

Golden Hour Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Neurol · 2024-06-25

该系统评价与Meta分析检索Medline、Embase和Web of Science数据库(从建库至2023年8月27日),纳入7项研究共78826例患者,比较黄金小时内与黄金小时外静脉溶栓的安全性和有效性。黄金小时内溶栓与更高的90天极好功能结局(OR 1.40,95%CI 1.16-1.67)和良好功能结局(OR 1.38,95%CI 1.13-1.69)相关,症状性颅内出血和死亡率两组相似。

要点

  • 黄金小时内静脉溶栓与更高90天极好功能结局相关(OR 1.40,95%CI 1.16-1.67)。
  • 黄金小时内溶栓每减少1例患者至少1个改良Rankin量表等级残疾的需治疗人数为2.6。
  • 症状性颅内出血率和死亡率在黄金小时内与黄金小时外溶栓组间相似。

核心结论

  • 黄金小时内溶栓显著改善急性缺血性卒中结局,为在发病后黄金小时窗口内加速溶栓治疗提供了依据。

研究设计与样本

  • 系统评价与Meta分析,系统检索Medline、Embase和Web of Science数据库从建库至2023年8月27日,纳入报告黄金小时内与较晚时间窗静脉溶栓安全性和有效性结局的研究,共纳入7项研究、78826例患者。

主要发现

  • 黄金小时内溶栓与更高的90天极好功能结局相关(OR 1.40,95%CI 1.16-1.67)。
  • 黄金小时内溶栓与更高的90天良好功能结局相关(OR 1.38,95%CI 1.13-1.69)。
  • 黄金小时内溶栓每减少1例患者至少1个改良Rankin量表等级残疾的需治疗人数为2.6。
  • 症状性颅内出血率和死亡率在黄金小时内与黄金小时外溶栓组间相似。

关键数值与推荐

  • 主要结局为90天极好功能结局,定义为改良Rankin量表评分0-1分。
  • 次要疗效结局为良好功能结局,定义为改良Rankin量表评分0-2分。
  • 主要安全结局为症状性颅内出血。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The benefits of intravenous thrombolysis are time-dependent, with maximum efficacy when administered within the first "golden" hour after onset. Nevertheless, the impact of golden hour thrombolysis has not been well quantified. METHODS: Medline, Embase, and Web of Science databases were systematically searched from inception to August 27, 2023. We included studies that reported safety and efficacy outcomes of ischemic stroke patients treated with intravenous thrombolysis in the golden hour versus later treatment window. The primary outcome was an excellent functional outcome, defined as a modified Rankin Scale score of 0-1 at 90 days. The secondary efficacy outcome was a good functional outcome (defined as modified Rankin Scale score of 0-2). The main safety outcome was symptomatic intracerebral hemorrhage. RESULTS: Seven studies involving 78,826 patients met the selection criteria. Golden hour thrombolysis was associated with higher odds of 90-day excellent functional outcomes (OR 1.40, 95% CI 1.16-1.67) and 90-day good functional outcomes (OR 1.38, 95% CI 1.13-1.69) compared with thrombolysis outside the golden hour. The number needed to treat to benefit for golden hour thrombolysis to reduce disability by at least 1 level on the modified Rankin Scale per patient was 2.6. Rates of symptomatic intracerebral hemorrhage and mortality were similar between groups. INTERPRETATION: Golden hour thrombolysis significantly improved acute ischemic stroke outcomes. The findings provide rationale for intensive efforts aimed at expediting thrombolytic therapy within the golden hour window following the onset of acute ischemic stroke. ANN NEUROL 2024;96:582-590.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Al-Ajlan FS, Alkhiri A, Alamri AF, et al. Golden Hour Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Ann Neurol. 2024. PMID: 38922985. doi:10.1002/ana.27007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。